The histopathology of necrotizing enterocolitis (NEC) is characterized by destruction of the mucosal layer in initial stages and by transmural necrosis of the intestinal wall in advanced stages of the disease. To test the hypothesis that enhanced epithelial apoptosis is an initial event underlying the gross histologic changes, we analyzed epithelial apoptosis and tissue morphology in an animal model of NEC and evaluated the effect of caspase inhibition on the incidence of experimental NEC in this model. Apoptosis was analyzed with terminal deoxynucleotidyltransferase-mediated dUTP-FITC nick end labeling (TUNEL) staining in intestinal sections and by measuring caspase 3 activity from intestinal lysates of neonatal rats subjected to formula feeding and cold/asphyxia stress (FFCAS) and from mother-fed (MF) controls. Morphologic evaluation was based on hematoxylin and eosin staining of intestinal sections. FFCAS resulted in histologic changes consistent with NEC, which were absent from MF animals. FFCAS was also associated with a significantly increased rate of nuclear DNA fragmentation in the small intestinal epithelium compared with MF. Elevated tissue caspase 3 activity confirmed the presence of apoptosis in samples with increased DNA fragmentation. Analysis of the coincidence of morphologic damage and apoptosis in corresponding tissue sections indicated that apoptosis precedes gross morphologic changes in this model. Furthermore, supplementation of formula with 8 boc-aspartyl(OMe)-fluoromethylketone, a pan-caspase inhibitor, significantly reduced the incidences of apoptosis and experimental NEC. These findings indicate that in neonatal rats FFCAS induces epithelial apoptosis that serves as an underlying cause for subsequent gross tissue necrosis. NEC occurs in 5-15% of premature infants born weighing Ͻ1500 g and remains one of the leading causes of death in these patients (1-3). Nonetheless, the etiology of NEC remains elusive, and no specific treatment or preventive approaches have been successful. Several lines of evidence suggest that neonatal risk factors of prematurity, asphyxia, intestinal ischemia, and formula feeding are all contributing to the occurrence of the disease (4 -6). The immaturity of mucosal host defense, inappropriate bacterial colonization profile, and an imbalance of endothelin-dependent vasoconstriction and nitric oxide-dependent vasodilatation have also been implicated in the disease (7-10). Among the many inflammatory mediators that have been identified as possible culprits in the pathogenesis of NEC, PAF has been shown to play a central role. Elevated serum PAF levels in NEC patients and decreased serum PAF acetylhydrolase (i.e. the PAF degrading enzyme) in premature neonates suggests a role for this molecule in NEC pathogenesis. Initial studies in adult rats using an acute model have shown that exogenous PAF given intravenously results in ischemic bowel necrosis (11) and endotoxin, hypoxia, or tumor necrosis factor (TNF)-induced intestinal injury can be prevented by PAF receptor (PAFR) antagonists (12, 13 
The histopathology of necrotizing enterocolitis (NEC) is characterized by destruction of the mucosal layer in initial stages and by transmural necrosis of the intestinal wall in advanced stages of the disease. To test the hypothesis that enhanced epithelial apoptosis is an initial event underlying the gross histologic changes, we analyzed epithelial apoptosis and tissue morphology in an animal model of NEC and evaluated the effect of caspase inhibition on the incidence of experimental NEC in this model. Apoptosis was analyzed with terminal deoxynucleotidyltransferase-mediated dUTP-FITC nick end labeling (TUNEL) staining in intestinal sections and by measuring caspase 3 activity from intestinal lysates of neonatal rats subjected to formula feeding and cold/asphyxia stress (FFCAS) and from mother-fed (MF) controls. Morphologic evaluation was based on hematoxylin and eosin staining of intestinal sections. FFCAS resulted in histologic changes consistent with NEC, which were absent from MF animals. FFCAS was also associated with a significantly increased rate of nuclear DNA fragmentation in the small intestinal epithelium compared with MF. Elevated tissue caspase 3 activity confirmed the presence of apoptosis in samples with increased DNA fragmentation. Analysis of the coincidence of morphologic damage and apoptosis in corresponding tissue sections indicated that apoptosis precedes gross morphologic changes in this model. Furthermore, supplementation of formula with 8 boc-aspartyl(OMe)-fluoromethylketone, a pan-caspase inhibitor, significantly reduced the incidences of apoptosis and experimental NEC. These findings indicate that in neonatal rats FFCAS induces epithelial apoptosis that serves as an underlying cause for subsequent gross tissue necrosis. NEC occurs in 5-15% of premature infants born weighing Ͻ1500 g and remains one of the leading causes of death in these patients (1) (2) (3) . Nonetheless, the etiology of NEC remains elusive, and no specific treatment or preventive approaches have been successful. Several lines of evidence suggest that neonatal risk factors of prematurity, asphyxia, intestinal ischemia, and formula feeding are all contributing to the occurrence of the disease (4 -6) . The immaturity of mucosal host defense, inappropriate bacterial colonization profile, and an imbalance of endothelin-dependent vasoconstriction and nitric oxide-dependent vasodilatation have also been implicated in the disease (7) (8) (9) (10) . Among the many inflammatory mediators that have been identified as possible culprits in the pathogenesis of NEC, PAF has been shown to play a central role. Elevated serum PAF levels in NEC patients and decreased serum PAF acetylhydrolase (i.e. the PAF degrading enzyme) in premature neonates suggests a role for this molecule in NEC pathogenesis. Initial studies in adult rats using an acute model have shown that exogenous PAF given intravenously results in ischemic bowel necrosis (11) and endotoxin, hypoxia, or tumor necrosis factor (TNF)-induced intestinal injury can be prevented by PAF receptor (PAFR) antagonists (12, 13) . Furthermore, PAFR antagonists, or recombinant human PAF acetylhydrolase supplementation to formula prevented experimental NEC in a neonatal rat model of the disease. Much less is known regarding the chain of events that occur at the cellular level during the onset of tissue damage. The mechanisms by which the aforementioned inflammatory mediators elicit the necrosis of intestinal tissues are poorly understood.
It has been suggested that increased mucosal permeability may be an early event in the pathogenesis of NEC, allowing for the translocation of bacteria, recruitment of polymorphonuclear leukocytes, and consequent tissue destruction (14, 15) . Because the mucosal barrier is formed by a layer of epithelial cells with tight junctions sealing the gap between the cells, increased epithelial permeability can be caused by loss of tight junctions or damage to the epithelial cells. FAS-mediated apoptosis of cultured T 84 colonic adenocarcinoma cells has been shown to cause an increase of transepithelial permeability, but this cultured cell monolayer also exhibited a remarkable ability to restore barrier function in the face of the loss of cells (16) . Key factors in NEC pathogenesis, such as hypoxia reoxygenation, PAF, TNF-␣, and endotoxin, have been shown to increase mucosal permeability (17) (18) (19) (20) (21) . Most of these mediators have been shown to cause apoptosis of intestinal epithelial cells as well (22) (23) (24) , but the connection between apoptosis and subsequent gross morphologic damage in NEC is yet to be elucidated.
Abundant epithelial apoptosis has been observed in intestinal villi in histologic specimens collected at the time of bowel resection in patients with NEC (25) , however it remains unknown whether the observed epithelial apoptosis underlies the gross tissue necrosis, or only coincides with the wide-spread tissue destruction in NEC. Apoptosis of intestinal epithelium occurs during morphogenesis (26, 27) and also mediates the physiologic turnover of enterocytes, but increased amounts of apoptosis have been correlated with pathologic conditions in the intestine as well (28 -30) . It is notable that intestinal epithelial apoptosis is induced by ischemia-reperfusion injury in vivo (24, 28, 30) , and by bacterial invasion (29) , peroxynitrite (31) , and the inflammatory cytokine TNF-␣ (29) in vitro. In a surgical model of intestinal ischemia-reperfusion injury, the specific inhibition of apoptosis by a peptide caspase inhibitor reduced histologic damage (28) , and the intestine-specific over-expression of bcl-2, a prototypical anti-apoptotic member of the bcl-2 gene family, resulted in protection from ischemiareperfusion-induced bowel necrosis (24) . In the neonatal rat model of NEC, intestinal ischemia-reperfusion injury is likely to play a role, as the cold stress after asphyxia is expected to augment and prolong intestinal ischemia (32) (33) (34) . Thus, given the suggested underlying role of apoptosis in intestinal ischemiareperfusion injury, we hypothesized that, in the neonatal rat model of NEC, epithelial apoptosis plays an early and underlying role in mucosal injury.
To test this hypothesis, we evaluated apoptosis in the small intestinal epithelium in neonatal rats subjected to FFCAS, and correlated the degree of epithelial apoptotic DNA fragmentation with the histologic damage to the intestinal wall. We have found an increased incidence of abundant epithelial apoptosis in sections of small intestine from neonatal rats that were subjected to FFCAS. We provide novel evidence suggesting that abundant apoptosis precedes gross morphologic damage, and that caspase inhibition significantly reduces the incidence of experimental NEC in this model.
MATERIALS AND METHODS

Materials.
The apoptosis detection system, fluorescein was from Promega (Madison, WI, U.S.A.). Caspase 3 enzymatic activity assay kits were from Biovision (San Diego, CA, U.S.A.), and BAF was from Enzyme Systems Products (Livermore, CA, U.S.A.). All other chemicals were from Sigma Chemical (St. Louis, MO, U.S.A.).
Neonatal rat model. All animal experiments were performed in accordance with the applicable animal welfare regulations and with the approval of the Institutional Animal Care and Use Committee (IACUC#A3444 -01). Experimental NEC was induced in neonatal rats with FFCAS based on a protocol originally described by Barlow and Santulli (35) and further developed in our laboratory (36) . Briefly, Pregnant SpragueDawley rats (Harlan Bioproducts for Science, Indianapolis, IN, U.S.A.) were obtained, and after preterm delivery by cesarean section at d 21 of pregnancy, newborns were removed from their mother. Neonatal rats were warmed at 37°C and humidified in a newborn incubator. After stabilization, an orogastric feeding tube (silastic catheter, 1.9F) was positioned and feedings instituted using neonatal animal formula (Esbilac, 200 cal/kg/d; PetAg, Hampshire, IL, U.S.A.) at 0.1 mL every 3 h for 36 h, then 0.2 mL every 3 h. Animals were weighed daily to document adequate nutritional intake. Hypoxia was accomplished by stressing each rat pup with 100% N 2 for 50 s, followed by exposure to cold (4°C) for 10 min two times daily. Some animals received caspase inhibitors as follows: BAF at a final concentration of 40 M in the formula dissolved from a 20 mM stock in DMSO. Vehicle control consisted of animals receiving DMSO at a 1:500 dilution in formula. The experiment was terminated at 24 or 48 h and surviving animals were killed by placing them in a chamber filled with 100% CO 2 for 5 min. Half of the intestinal block was fixed in 4% buffered paraformaldehyde and processed for paraffin embedding, sectioning, and H&E or TUNEL staining, and the other half was snap frozen in liquid nitrogen, then stored at Ϫ80°C for tissue extraction and caspase activity measurement.
TUNEL staining. Formalin-fixed, paraffin-embedded intestinal tissue sections were deparaffinized, treated with proteinase K, and labeled by terminal deoxynucleotide transferase TdT enzyme added along with nucleotide mix including fluorescein-dUTP conjugate. After labeling, preparations were washed and nuclei counter-stained with HOE33258, then slides were mounted with anti-fade reagent (Molecular Probes, Eugene, OR, U.S.A.). In each set of samples, a slide was processed without TdT (negative control) to ensure specificity of positively stained apoptotic bodies. Slides were examined with fluorescence digital imaging or with deconvolution confocal fluorescence imaging using a 20ϫ objective and the following fluorescence filters: HOE33258 ex: 360 Ϯ 20, em: 420 Ϯ 20, and FITC ex: 480 Ϯ 20, em: 530 Ϯ 20. Fluorescence images were then pseudo-colored and overlaid to illustrate the localization of TUNEL positive nuclei relative to all nuclei in the intestine. Specimens were also surveyed by a blinded investigator at a lower magnification using a 5ϫ objective and were assigned a score in a range of 0 -4.
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Scoring of TUNEL-stained and H&E-stained slides. TUNEL-stained and H&E-stained histologic slides were examined by a blinded observer, and were assigned a score on the scale of 0 -4. Slides were prepared such that the H&E-stained and the corresponding TUNEL-stained slides were from the same set of serial sections from the same block. To illustrate the scoring criteria, Figure 1 summarizes in a schematic the morphologic features (Fig. 1a) and the localization of TUNELpositive nuclei (Fig. 1a and b) in specimens where apoptosis was observed in the absence of morphologic damage (Fig. 1b) or when apoptosis was associated with histologic damage (Fig.  1a) . Score 0 (both NEC and apoptosis) was assigned to specimens where the villous epithelium was continuous, and only solitaire TUNEL positive nuclei were observed. Specimens with clusters of TUNEL-positive nuclei on the villous tips were assigned an apoptosis score of 1. Apoptosis score of 2 was assigned to specimens with apoptotic nuclei covering the villous, but crypts were completely spared from apoptosis. Apoptosis score 3 required apoptosis penetrating into the crypts, and apoptosis score 4 was given to specimens with transmural distribution of TUNEL-positive nuclei. The corresponding NEC scores were based on a similar scoring scheme. Intact villi received a score of 0, sloughing of cells on villous tips was assigned a score of 1, and mid-villous damage was scored as 2. NEC score of 3 was assigned when villi were absent, but crypts were still readily detectable; and NEC score of 4 was recorded in cases of complete absence of epithelial structures and transmural necrosis. Scores were always determined based on the highest score observed in a specimen. To evaluate significance of changes between groups, the total number of observations in each group was divided into two groups based on H&E scores [NEC (ϩ) and NEC(Ϫ)] and also in two groups based on TUNEL scores [apoptosis (ϩ) and apoptosis (Ϫ)], and the difference between groups was analyzed using 2 test. Furthermore, the co-existence of apoptosis and necrosis was analyzed, and each specimen received a classification in the following categories: 1) apoptosis (Ϫ)/NEC (Ϫ), 2) apoptosis (ϩ)/NEC (Ϫ), and 3) apoptosis (ϩ)/NEC (ϩ). In the entire set of samples analyzed there was only one specimen that could be categorized as apoptosis (Ϫ)/NEC (ϩ), and thus, this category was ignored in further analyses.
Measurement of caspase activity. Caspase 3 enzymatic activity was analyzed using DEVD-AFC fluorogenic substrate from intestinal tissue lysates using a kit (Biovision, San Diego, CA), according to the manufacturer's instructions. Briefly, 10-mm-long segments of neonatal rat intestine were rinsed and homogenized in ice-cold PBS, then lysed in the lysis buffer provided by the manufacturer for 20 min on ice. The protein Histological NEC and apoptosis scores were determined based on the scoring scheme described in "Materials and Methods" and samples exhibiting scores Ͼ1 were identified as NEC (ϩ), or apoptosis (ϩ).
* Overall significance p Ͻ 0.01 using 2 test. Histological NEC score was determined based on the scoring scheme described in "Materials and Methods" and samples exhibiting scores Ͼ1 were identified as NEC (ϩ). concentrations of the lysates were determined using the BCA colorimetric assay. Subsequently, cell lysates representing equal amounts of protein were mixed with DEVD-AFC, and in parallel reactions with DEVD-AFC and Z-DEVD-FMK (i.e. caspase 3 inhibitory peptide) in incubation buffer (20 mM HEPES, pH 7.5, 10% glycerol, 2 mM DTT). After incubation at 37°C for 1 h, fluorescence was measured at ex ϭ 380 nm, em ϭ 450 nm. Fluorescence intensity of DEVD-AFCϩZ-DEVD-FMK-containing reactions was subtracted from the corresponding reactions containing DEVD-AFC only to calculate specific signal.
Statistical analysis. To evaluate changes in caspase 3 activity, specific fluorescence intensities were normalized to the mean intensity of samples representing MF controls, and were expressed as percentage control. Data were analyzed with t test. To evaluate the statistical significance between the incidences of NEC and apoptosis in the various groups, the numbers of observations in each category of each group were entered into contingency tables and analyzed using 2 test. For data presented in Table 1 , 24 h MF was compared with 24 h FFCAS in 2 ϫ 2 2 , 48 h MF was compared with 48 h FFCAS, and the combined numbers at 24 and 48 h were also analyzed. For the data shown in Table 2 , the numbers of observations were analyzed in 2 ϫ 3 2 . For both analyses, ␣ Ͻ 0.05 and statistical significance were considered at p Ͻ 0.05.
RESULTS
Abundant epithelial apoptosis in experimental NEC.
We hypothesized that intestinal epithelial apoptosis is an early event in NEC pathogenesis that might underlie subsequent bowel wall necrosis. As shown in Figure 2 , we observed a dramatic increase in the frequency of nuclei exhibiting DNA fragmentation in the epithelial layer of FFCAS animals (Fig.  2b) , compared with MF controls (Fig. 2a) . To assess the relationship between DNA fragmentation in enterocytes and tissue necrosis in the intestine, we developed a scoring scheme to quantitatively evaluate these alterations (see "Materials and Methods"). Figure 2 , c-g, depicts examples of TUNEL-stained sections of rat small bowel, illustrating the basis of apoptosis scoring scheme. Figure 2 , b, e, and f, are typical examples of tissue regions where intense TUNEL-positive staining is observed in the top half of the villi (apoptosis score ϭ 2 or 3), but there were no noticeable alterations in morphology based on the morphology deciphered from the nuclear counter-stain (red) and the scoring of corresponding H&E-stained speci- 
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mens. To obtain a corresponding unbiased score regarding morphologic damage, slides cut from the same block were stained with H&E and scored based on the criteria outlined in methods. Figure 3 illustrates examples of each score.
Elevated caspase activity in intestinal samples exhibiting enhanced TUNEL-positive staining. Given that TUNEL staining has been known to produce false-positive reactions occasionally, we measured caspase 3 activity from a selected set of samples. We selected lysates of intestinal segments from FF-CAS-treated animals that corresponded to histologic specimens where we observed apoptosis score Ͼ1, but normal histology (NEC score ϭ 0 or 1), and compared caspase activity in these samples to caspase activity in intestinal segments from MF animals that exhibited only baseline levels of DNA fragmentation (score 0). We have found significantly elevated caspase 3 activity from tissue lysates (Fig. 4 ) of FFCAS animals that had apoptosis scores Ͼ1, confirming that the TUNEL-positive staining represented apoptosis.
FFCAS results in a significantly increased incidence of NEC and epithelial apoptosis. Figure 4 summarizes our data obtained by determining H&E scores and corresponding TUNEL scores in a large number of specimens. Figure 5a illustrates the distribution of NEC scores at 24 h and 48 h in MF and in FFCAS animals, and corresponding apoptosis scores are shown in Figure 5b . Grades Ͼ1 in both NEC scores and in apoptosis scores were clearly associated with FFCAS in a time-dependent manner (i.e. scores Ͼ1 increased from 24 to 48 h in the FFCAS group). To statistically evaluate these changes, we designated NEC grades Ͼ1 as pathologic, or NEC (ϩ), and apoptosis scores Ͼ1 as pathologically increased apoptosis, or apoptosis (ϩ). Based on these criteria, we assigned each sample into NEC (ϩ) or NEC (Ϫ) and an apoptosis (ϩ) and apoptosis (Ϫ) category. By examining the distribution of these categories among MF and FFCAS neonatal rats we found that there was a highly significant (p Ͻ 0.001) increase in the rate of both NEC (ϩ) and apoptosis (ϩ) in the FFCAS group (Table 1) .
Increased apoptosis precedes histologic NEC. To determine whether accelerated apoptosis can be viewed as a potential initiating event in NEC, we determined whether apoptosis precedes NEC in this model. Because the neonatal rat model of NEC does not allow the sampling of tissues at various time points in the same animal, we designed an indirect method to evaluate the relative timing of enhanced apoptosis and NEC. We hypothesized that if apoptosis precedes NEC, we should identify apoptosis (ϩ) in several samples before histologic evidence of NEC has occurred, and in every specimen demonstrating NEC (ϩ), apoptosis should be present. We tested the coincidence of these two designations for each sample (Fig. 6 ) and found that the data perfectly fit our hypothesis and every specimen exhibiting NEC (ϩ) was also apoptosis (ϩ), and, in approximately one third of specimens from FFCAS-treated neonatal rats, we found evidence of pathologically increased apoptosis but no signs of pathologic histology. These findings are consistent with our hypothesis that enhanced apoptosis precedes, and perhaps underlies, gross histologic alterations.
Supplementation of formula with BAF, a pan-caspase inhibitor attenuates the incidence of histologic NEC. Because our analysis of NEC and apoptosis scores suggested that enhanced apoptosis precedes gross histologic changes, we wanted to evaluate whether apoptosis underlies subsequent morphologic damage. To address this issue we used BAF, a pan-caspase inhibitor supplemented in formula to inhibit intestinal apoptosis, and compared the incidence of apoptosis (ϩ) and NEC (ϩ) in the presence and absence of caspase inhibition. As expected, inclusion of BAF into the formula significantly reduced the rate of pathologic DNA fragmentation in FFCAS-treated neonatal rats ( Table 2 , top). More importantly, BAF also decreased the rate of histologic NEC in these animals, indicating that inhibition of apoptosis prevented experimental NEC.
DISCUSSION
NEC is one of the leading causes of death for premature infants weighting Ͻ1500 g. Despite intense research efforts, only two risk factors-prematurity and formula feeding-have been unambiguously identified for this disease. Additional factors that have been suggested to contribute to the etiology are hypoxia, hypotension, undeveloped regulation of intestinal circulation (7), and intestinal colonization of pathologic bacteria (37) . Feeding with mother's milk has been shown to provide some protection against NEC, albeit by unknown mechanism(s) (38) . Analysis of serum and fecal samples from affected infants, surgical specimens obtained during bowel resection, and experimental data from animal models of NEC have identified PAF, TNF-␣, nitric oxide, and lipopolysaccharides as potential key mediators of the disease (11, 25, 39, 40) . Increase of mucosal permeability has been reported in animal models of NEC, and it was suggested that this increased mucosal permeability, the ensuing bacterial translocation to the submucosa, and the activation of the secondary inflammatory cascade are key steps in the final collapse of mucosal integrity (41) . The permeability barrier between the lumen of the gut and the submucosa is formed by a layer of epithelial cells and a seal composed by tight junctions between the epithelial cells. The two obvious mechanisms that may lead to a collapse of this barrier function are the loss of tight junctions and/or the loss of cells. Although our study was not designed to specifically evaluate the role of apoptosis in mucosal barrier function, our data are consistent with the notion that a loss of cells due to pathologically increased rates of epithelial apoptosis might significantly contribute to the increased mucosal permeability 
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in NEC. These findings are in agreement with results from human bowel specimens that were obtained from surgical treatment of NEC that revealed the presence of increased DNA fragmentation in the intestinal epithelium in NEC (25) .
At the molecular level, apoptosis is regulated by a number of converging signaling cascades that influence each other at various checkpoints along their progression. In most cases, apoptosis involves the activation of select caspases that are characteristic of the signal event initiating apoptosis (42) . Nevertheless, DNA fragmentation can occur in the absence of detectable caspase activation (43) or even in necrosis (44) . Therefore, we have found it important to measure caspase activity from intestinal lysates as a confirmation that the detected TUNEL staining correlates with enhanced apoptotic activity. The results show that FFCAS-induced increased DNA fragmentation, as detected with TUNEL staining, correlates with elevated tissue caspase 3 activity. Furthermore, BAF, a pan-caspase inhibitor, significantly reduced the incidence of pathologically elevated level of DNA fragmentation. These findings indicate that FFCAS elicits DNA fragmentation in intestinal epithelial cells of neonatal rats via caspase activation, and that the observed TUNEL staining is indicative of apoptosis.
Apoptosis is an underlying mechanism for a number of physiologic processes, including organ development, the elimination of autoreactive lymphocytes, and the resolution of inflammation. Defective regulation of apoptosis has been considered in a number of pathologic conditions (45) . For example, aberrant expression of anti-apoptotic gene products has been implicated in malignancies (46) and defective regulation of apoptosis might be the underlying mechanism in the pathology of autoimmune diseases (47) . Ischemia reperfusion injury causes apoptosis in the epithelium of the small intestine (24, 30) in a manner that can be prevented by the forced overexpression of the anti-apoptotic gene bcl-2 (24) . It is unknown whether this increased rate of apoptosis is an underlying mechanism of tissue damage, or if it occurs as a form of necessary demolition before tissue restoration. To investigate this issue in our model, we asked the question whether apoptosis precedes gross tissue necrosis. In the neonatal model of NEC it is impossible to follow the course of events within the same animal, therefore, we had to rely on an indirect method to investigate this issue. We postulated the following: If apoptosis precedes NEC, every section with histologic damage has to exhibit increased apoptosis, and there has to be a number of specimens where apoptosis is observed even in the absence of detectable tissue necrosis. Abundant TUNEL-positive staining was observed in every tissue section that corresponded to the histologic evidence of NEC in H&E-stained serial sections. More significantly, in many cases we observed TUNEL positivity in sections where the corresponding H&E-stained serial sections lacked evident signs of tissue necrosis. These data indicate that epithelial apoptosis occurs before gross tissue necrosis. To determine whether there is a cause and consequence relationship between epithelial apoptosis and gross tissue necrosis we used a pan-caspase inhibitor, BAF, to block apoptosis and to evaluate whether blocking apoptosis can prevent gross histologic damage in our model. Including BAF in the formula significantly reduced the incidence of apoptosis and NEC in neonatal rats. These data strongly suggest that an increase in the rate of epithelial apoptosis does not only precede the subsequent gross intestinal wall necrosis, but that it is an underlying cause. Further studies will be required to determine the reason for the acceleration of epithelial apoptosis in this model, to investigate the role of apoptosis in increased mucosal permeability, and to investigate the mechanism that leads to massive tissue destruction on the basis of the epithelial damage.
CONCLUSION
In summary, our studies indicate that abundant apoptosis of the intestinal epithelium precedes widespread tissue damage in an experimental model of neonatal NEC. Given that caspase inhibition protects neonatal rats from FFCAS-induced intestinal injury, apoptosis appears to be an underlying cause of subsequent gross mucosal damage in this model. Although it is unclear whether caspase inhibition could be used safely in the newborn as a potential therapeutic strategy, a better understanding of signaling and execution mechanisms that lead to programmed cell death in enterocytes might provide the basis for the design of future therapeutic and/or preventative strategies for NEC. 
